Murine filaggrin-2 is involved in epithelial barrier function and down-regulated in metabolically induced skin barrier dysfunction

Experimental Dermatology

Volumn 21, Issue 4, 2012, Pages 271-276

  Hansmann, Britta ^a   Ahrens, Kerstin ^a   Wu, Zhihong ^a   Proksch, Ehrhardt ^a   Meyer Hoffert, Ulf ^a   Schröder, Jens Michael ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Atopic dermatitis; Eczema; Epidermal barrier; Filaggrin; Filaggrin 2

Indexed keywords

CALCIUM; COMPLEMENTARY DNA; FILAGGRIN; FILAGGRIN 2; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DOWN REGULATION; EPIDERMAL BARRIER FUNCTION; EPIDERMIS; ESSENTIAL FATTY ACID DEFICIENCY; IMMUNOBLOTTING; KERATINOCYTE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; SKIN DEFECT; SKIN FUNCTION; UPREGULATION;

ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; CELLS, CULTURED; DERMATITIS, ATOPIC; DNA PRIMERS; DNA, COMPLEMENTARY; DOWN-REGULATION; EPIDERMIS; FATTY ACIDS, ESSENTIAL; HUMANS; ICHTHYOSIS VULGARIS; INTERMEDIATE FILAMENT PROTEINS; KERATINOCYTES; MICE; MICE, HAIRLESS; MICE, INBRED BALB C; RNA, MESSENGER; S100 PROTEINS; SKIN DISEASES;

EID: 84858416244     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2012.01449.x     Document Type: Article

References (58)

1. Moseley W S, Seldin M F. Genomics 1989: 5: 899-905.
2. Volz A, Korge B P, Compton J G et al. Genomics 1993: 18: 92-99.
3. Mischke D, Korge B P, Marenholz I et al. J Invest Dermatol 1996: 106: 989-992.
4. Jackson B, Tilli C M, Hardman M J et al. J Invest Dermatol 2005: 124: 1062-1070.
5. Lonsdale-Eccles J D, Teller D C, Dale B A. Biochemistry 1982: 21: 5940-5948.
6. Dale B A, Scofield J A, Hennings H et al. J Invest Dermatol 1983: 81: 90s-95s.
7. Dale B A, Ling S Y. Biochemistry 1979: 18: 3539-3546.
8. Rogers G E, Harding H W, Llewellyn-Smith I J. Biochim Biophys Acta 1977: 495: 159-175.
9. Rothnagel J A, Rogers G E. J Cell Biol 1986: 102: 1419-1429.
10. Wu Z, Latendorf T, Meyer-Hoffert U et al. J Invest Dermatol 2011: 131: 1761-1763.
11. Krieg P, Schuppler M, Koesters R et al. Genomics 1997: 43: 339-348.
12. Huber M, Siegenthaler G, Mirancea N et al. J Invest Dermatol 2005: 124: 998-1007.
13. Makino T, Takaishi M, Morohashi M et al. J Biol Chem 2001: 276: 47445-47452.
14. Takaishi M, Makino T, Morohashi M et al. J Biol Chem 2005: 280: 4696-4703.
15. Contzler R, Favre B, Huber M et al. J Invest Dermatol 2005: 124: 990-997.
16. Wu Z, Hansmann B, Meyer-Hoffert U et al. PLoS One 2009: 4: e5227.
17. Toulza E, Mattiuzzo N R, Galliano M F et al. Genome Biol 2007: 8: R107.
18. Marenholz I, Heizmann C W, Fritz G. Biochem Biophys Res Commun 2004: 322: 1111-1122.
19. Steinert P M, Marekov L N. J Biol Chem 1995: 270: 17702-17711.
20. Lynley A M, Dale B A. Biochim Biophys Acta 1983: 744: 28-35.
21. Lonsdale-Eccles J D, Haugen J A, Dale B A. J Biol Chem 1980: 255: 2235-2238.
22. Palmer C N, Irvine A D, Terron-Kwiatkowski A et al. Nat Genet 2006: 38: 441-446.
23. O'Regan G M, Campbell L E, Cordell H J et al. J Allergy Clin Immunol 2010: 125: 170-174.
24. Esparza-Gordillo J, Weidinger S, Folster-Holst R et al. Nat Genet 2009: 41: 596-601.
25. Broccardo C J, Mahaffey S, Schwarz J et al. J Allergy Clin Immunol 2011: 127: 186-193.
26. Hsu C Y, Henry J, Raymond A A et al. J Biol Chem 2011: 286: 23222-23233.
27. Larkin M A, Blackshields G, Brown N P et al. Bioinformatics 2007: 23: 2947-2948.
28. Nicholas K B, Nicholas H B, Deerfield D W. Embnet.news 1997: 4: 14.
29. Altschul S F, Madden T L, Schaffer A A et al. Nucleic Acids Res 1997: 25: 3389-3402.
30. Schultz J, Milpetz F, Bork P et al. Proc Natl Acad Sci USA 1998: 95: 5857-5864.
31. Heger A, Holm L. Proteins 2000: 41: 224-237.
32. Bavandi A, Meingassner J G, Becker S. Exp Dermatol 1992: 1: 199-205.
33. Caldelari R, Suter M M, Baumann D et al. J Invest Dermatol 2000: 114: 1064-1065.
34. Rice R H, Green H. Cell 1977: 11: 417-422.
35. Bibel D J, Miller S J, Brown B E et al. J Invest Dermatol 1989: 92: 632-638.
36. Proksch E, Feingold K R, Man M Q et al. J Clin Invest 1991: 87: 1668-1673.
37. Proksch E, Feingold K R, Elias P M. J Invest Dermatol 1992: 99: 216-220.
38. Mathay C, Pierre M, Pittelkow M R et al. J Invest Dermatol 2011: 131: 46-58.
39. Sandilands A, Sutherland C, Irvine A D et al. J Cell Sci 2009: 122: 1285-1294.
40. Presland R B, Kuechle M K, Lewis S P et al. Exp Cell Res 2001: 270: 199-213.
41. Dale B A, Presland R B, Lewis S P et al. J Invest Dermatol 1997: 108: 179-187.
42. Pearton D J, Dale B A, Presland R B. J Invest Dermatol 2002: 119: 661-669.
43. Zhang D, Karunaratne S, Kessler M et al. J Invest Dermatol 2002: 119: 905-912.
44. Listwan P, Rothnagel J A. Methods Cell Biol 2004: 78: 817-827.
45. Harding C R, Watkinson A, Rawlings A V et al. Int J Cosmet Sci 2000: 22: 21-52.
46. Rawlings A V, Scott I R, Harding C R et al. J Invest Dermatol 1994: 103: 731-741.
47. Scott I R, Harding C R, Barrett J G. Biochim Biophys Acta 1982: 719: 110-117.
48. Seguchi T, Cui C Y, Kusuda S et al. Arch Dermatol Res 1996: 288: 442-446.
49. Irvine A D, McLean W H. J Invest Dermatol 2006: 126: 1200-1202.
50. Sandilands A, O'Regan G M, Liao H et al. J Invest Dermatol 2006: 126: 1770-1775.
51. Weidinger S, Illig T, Baurecht H et al. J Allergy Clin Immunol 2006: 118: 214-219.
52. Proksch E, Brandner J M, Jensen J M. Exp Dermatol 2008: 17: 1063-1072.
53. Lee K H, Cho K A, Kim J Y et al. Exp Dermatol 2011: 20: 149-151.
54. Kezic S, Kemperman P M, Koster E S et al. J Invest Dermatol 2008: 128: 2117-2119.
55. O'Regan G M, Kemperman P M, Sandilands A et al. J Allergy Clin Immunol 2010: 126: 574-580.
56. Hou S Y, Mitra A K, White S H et al. J Invest Dermatol 1991: 96: 215-223.
57. Wertz P W, Cho E S, Downing D T. Biochim Biophys Acta 1983: 753: 350-355.
58. Ekanayake-Mudiyanselage S, Aschauer H, Schmook F P et al. J Invest Dermatol 1998: 111: 517-523.